BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $782,000 | – | 35,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaCentric Advisors LLC | 50,000 | $1,017,000 | 0.30% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $407,000 | 0.29% |
| Knoll Capital Management, LLC | 20,000 | $407,000 | 0.22% |
| Artemis Investment Management LLP | 1,410,382 | $28,604,000 | 0.21% |
| CNA FINANCIAL CORP | 14,359 | $292,000 | 0.08% |
| Virtus ETF Advisers LLC | 8,164 | $166,000 | 0.06% |
| Aquatic Capital Management LLC | 1,300 | $26,000 | 0.05% |
| HITE Hedge Asset Management LLC | 16,397 | $333,000 | 0.04% |
| AllSquare Wealth Management LLC | 3,162 | $64,000 | 0.04% |
| Capital Investment Advisory Services, LLC | 14,075 | $286,000 | 0.03% |